Benefits of implantable cardiac defibrillators in heart failure are confirmedBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7441.664-a (Published 18 March 2004) Cite this as: BMJ 2004;328:664
- Janice Hopkins Tanne
- New York
Implantable cardiac defibrillators significantly reduce mortality in patients with heart failure and impaired left ventricular function, a new study shows.
Dr Gust Bardy of the Seattle Institute for Cardiac Research, Washington, reported the study to the conference.
The sudden cardiac death in heart failure trial (SCD-HeFT) was a randomised controlled trial of an implantable cardiac defibrillator in addition to standard treatment. It reduced mortality by 23% in a five year study of 2521 patients at …
Log in using your username and password
Log in through your institution
Sign up for a free trial